According to Oramed Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 40,445,896. At the end of 2023 the company had 40,445,896 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 40.44 M | 3.44% |
2022 | 39.1 M | 6.62% |
2021 | 36.67 M | 54.38% |
2020 | 23.75 M | 35.96% |
2019 | 17.47 M | 0.14% |
2018 | 17.44 M | 22.54% |
2017 | 14.23 M | 7.83% |
2016 | 13.2 M | 14.11% |
2015 | 11.57 M | 14.11% |
2014 | 10.14 M | 27.72% |
2013 | 7.94 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Novo Nordisk NVO | 4,459,600,000 | 10,926.09% | ๐ฉ๐ฐ Denmark |
Sanofi SNY | 2,497,600,000 | 6,075.16% | ๐ซ๐ท France |
Ultragenyx RARE | 71,664,493 | 77.19% | ๐บ๐ธ USA |
Lexicon Pharmaceuticals
LXRX | 244,925,000 | 505.56% | ๐บ๐ธ USA |
Compugen CGEN | 88,310,329 | 118.34% | ๐ฎ๐ฑ Israel |